32 results
8-K
EX-1.1
NKTX
Nkarta Inc
28 Mar 24
Other Events
4:08pm
and Drug Administration of the U.S. Department of Health and Human Services (“FDA”) or comparable federal, state, local or foreign governmental bodies … ”) that is, or is owned or controlled by a Person that is: (i) the subject of any sanctions administered or enforced by the U.S. Department of Treasury’s Office
8-K
EX-99.1
onfkx
17 Oct 23
Nkarta Receives FDA Clearance of IND Application for NKX019 in Lupus Nephritis
7:06am
PRE 14A
9hmt3
14 Apr 23
Preliminary proxy
5:00pm
8-K
EX-1.1
xqn hgcgp5r4
28 Apr 22
Other Events
4:20pm
S-3
EX-1.2
c21 a7rumgn4
12 Aug 21
Shelf registration
5:04pm
8-K
EX-10.1
ol9pbhy66a2nr1ksw271
14 Jul 21
Entry into a Material Definitive Agreement
7:07am
DEF 14A
2isove
22 Apr 21
Definitive proxy
12:35pm
10-K
ncakj
25 Mar 21
Annual report
12:00am
8-K
EX-10.1
xqimn
5 Oct 20
Nkarta Announces Leadership Changes
4:15pm
8-K
EX-99.1
aq3a0rn
14 Jul 20
Amendments to Articles of Incorporation or Bylaws
4:10pm